| Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells S Matsuyama, N Nao, K Shirato, M Kawase, S Saito, I Takayama, ... Proceedings of the National Academy of Sciences 117 (13), 7001-7003, 2020 | 1443 | 2020 |
| Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development M Imai, K Iwatsuki-Horimoto, M Hatta, S Loeber, PJ Halfmann, ... Proceedings of the National Academy of Sciences 117 (28), 16587-16595, 2020 | 1006 | 2020 |
| SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo YJ Hou, S Chiba, P Halfmann, C Ehre, M Kuroda, KH Dinnon III, SR Leist, ... Science 370 (6523), 1464-1468, 2020 | 924 | 2020 |
| The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan T Takahashi, K Maeda, T Suzuki, A Ishido, T Shigeoka, T Tominaga, ... The Journal of infectious diseases 209 (6), 816-827, 2014 | 832 | 2014 |
| Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo K Niikura, T Matsunaga, T Suzuki, S Kobayashi, H Yamaguchi, Y Orba, ... ACS nano 7 (5), 3926-3938, 2013 | 653 | 2013 |
| SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Nature 603 (7902), 687-692, 2022 | 515 | 2022 |
| SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity S Ozono, Y Zhang, H Ode, K Sano, TS Tan, K Imai, K Miyoshi, ... Nature communications 12 (1), 848, 2021 | 429 | 2021 |
| Pathology of congenital Zika syndrome in Brazil: a case series RB Martines, J Bhatnagar, AM de Oliveira Ramos, HPF Davi, ... The Lancet 388 (10047), 898-904, 2016 | 402 | 2016 |
| Efficacy of antibodies and antiviral drugs against Omicron BA. 2.12. 1, BA. 4, and BA. 5 subvariants E Takashita, S Yamayoshi, V Simon, H Van Bakel, EM Sordillo, A Pekosz, ... New England Journal of Medicine 387 (5), 468-470, 2022 | 290 | 2022 |
| Zika virus RNA replication and persistence in brain and placental tissue J Bhatnagar, DB Rabeneck, RB Martines, S Reagan-Steiner, Y Ermias, ... Emerging infectious diseases 23 (3), 405, 2017 | 257 | 2017 |
| Efficacy of antiviral agents against omicron subvariants BQ. 1.1 and XBB M Imai, M Ito, M Kiso, S Yamayoshi, R Uraki, S Fukushi, S Watanabe, ... New England Journal of Medicine 388 (1), 89-91, 2023 | 221 | 2023 |
| Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA. 2 R Uraki, M Kiso, S Iida, M Imai, E Takashita, M Kuroda, PJ Halfmann, ... Nature 607 (7917), 119-127, 2022 | 193 | 2022 |
| The human polyoma JC virus agnoprotein acts as a viroporin T Suzuki, Y Orba, Y Okada, Y Sunden, T Kimura, S Tanaka, K Nagashima, ... PLoS pathogens 6 (3), e1000801, 2010 | 176 | 2010 |
| Gold nanoparticle‐adjuvanted S protein induces a strong antigen‐specific IgG response against severe acute respiratory syndrome‐related coronavirus infection, but fails to … H Sekimukai, N Iwata‐Yoshikawa, S Fukushi, H Tani, M Kataoka, ... Microbiology and immunology 64 (1), 33-51, 2020 | 170 | 2020 |
| The Host Protease TMPRSS2 Plays a Major Role in In Vivo Replication of Emerging H7N9 and Seasonal Influenza Viruses K Sakai, Y Ami, M Tahara, T Kubota, M Anraku, M Abe, N Nakajima, ... Journal of virology 88 (10), 5608-5616, 2014 | 170 | 2014 |
| Lethal canine distemper virus outbreak in cynomolgus monkeys in Japan in 2008 K Sakai, N Nagata, Y Ami, F Seki, Y Suzaki, N Iwata-Yoshikawa, T Suzuki, ... Journal of virology 87 (2), 1105-1114, 2013 | 157 | 2013 |
| Mucosal IgA responses in influenza virus infections; thoughts for vaccine design E van Riet, A Ainai, T Suzuki, H Hasegawa Vaccine 30 (40), 5893-5900, 2012 | 156 | 2012 |
| Clinicopathologic and immunohistochemical findings from autopsy of patient with COVID-19, Japan T Adachi, JM Chong, N Nakajima, M Sano, J Yamazaki, I Miyamoto, ... Emerging infectious diseases 26 (9), 2157, 2020 | 151 | 2020 |
| Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related … N Iwata-Yoshikawa, A Uda, T Suzuki, Y Tsunetsugu-Yokota, Y Sato, ... Journal of virology 88 (15), 8597-8614, 2014 | 146 | 2014 |
| Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants S Moriyama, Y Adachi, T Sato, K Tonouchi, L Sun, S Fukushi, S Yamada, ... Immunity 54 (8), 1841-1852. e4, 2021 | 135 | 2021 |
